View in EDS

Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: current evidence and clinical implications.

Saved in:
Bibliographic Details
Title: Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: current evidence and clinical implications.
Authors: Willisch P; Department of Radiation Oncology, Hospital Meixoeiro, Vigo, Spain., Vázquez-Barreiro B; Department of Radiation Oncology, Hospital Meixoeiro, Vigo, Spain., Plata A; Department of Urology, Hospital Universitario de Canarias, San Cristóbal de La Laguna, Spain., Belmonte IC; Department of Urology, Hospital Virgen del Puerto, Cáceres, Spain., Guardia G; Department of Radiation Oncology, GenesisCare, Madrid, Spain., Del Castillo-Acuña R; Department of Radiation Oncology, Hospital Universitario Punta Europa, Algeciras, Spain., Francolini G; Department of Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy., Franzese C; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Department of Radiotherapy and Radiosurgery, IRCCS Humanitas Research Hospital, Milan, Italy., Henríquez JDS; Department of Urology, Hospital Universitario Ramon y Cajal, Madrid, Spain.; IRYCIS, Universidad de Alcalaá, Madrid, Spain., Couñago F; Department of Radiation Oncology, GenesisCare-La Milagrosa University Hospital Madrid, 28010, Madrid, Spain. fcounago@gmail.com.; Department of Radiation Oncology, GenesisCare-San Francisco de Asís University Hospital, 28002, Madrid, Spain. fcounago@gmail.com.; Department of Medicine, Faculty of Medicine, Health and Sport Sciences, Universidad Europea de Madrid, 28670, Madrid, Spain. fcounago@gmail.com., López-Campos F; Department of Radiation Oncology, GenesisCare-La Milagrosa University Hospital Madrid, 28010, Madrid, Spain.; Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, 28034, Madrid, Spain.
Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 Apr 10. Date of Electronic Publication: 2026 Apr 10.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1699-3055
DOI:10.1007/s12094-026-04350-4